This usually means waiting a bit longer between doses, not shorter
While clinical data shows semaglutide is generally well-tolerated, some patients report difficulty sleeping after starting the medication
However, ongoing safety monitoring on Hers depends on patient-initiated check-ins rather than mandatory follow-up labs or clinical assessments, which may delay detection of dose-related complications or emerging health concerns
Consult a healthcare provider.
Comparison Case: Some attorneys reference the Benicar MDL, where a blood pressure medications failure to warn about gastrointestinal side effects resulted in reported settlements of $300-360 million for 2,300 plaintiffs (averaging over $100,000 per case, with severe cases receiving $500,000+)
Important distinction: "Legal to compound" under 503A is NOT the same as "FDA approved." An FDA-approved drug has gone through full clinical trials and received a New Drug Application (NDA) approval